Brief: Takeda Pharmaceutical Reports 6.6% Stake In Phathom Pharmaceuticals
25/01/2024 12:44
Jan 25 (Reuters) - Takeda Pharmaceutical Co Ltd
4502.T :
* TAKEDA PHARMACEUTICAL COMPANY LTD REPORTS 6.6% STAKE IN
PHATHOM
PHARMACEUTICALS AS OF JAN 24, 2024 VERSUS 19.2% AS OF NOV 9,
2021 - SEC FILING
Further company coverage: 4502.T
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Phathom Pharmaceuticals
See all newsBrief: Phathom Pharma Provides Update On Litigation Filed By BDR Pharma Against FDA
Phathom Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Phathom Pharmaceuticals Q2 revenue beats on Voquezna prescription growth
Brief: Phathom Pharmaceuticals Q2 Net Income USD -17.582 Million
Phathom Pharmaceuticals Q1 revenue more than doubles, beats estimates